Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole for Cisplatin-Induced Nephrotoxicity in Head and Neck Cancer
NCT04217512Phase 3Recruiting
- Start
- May 2019
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pantoprazole in cisplatin-induced nephrotoxicity (CIN). Started May 2019; status: recruiting.
02
Drugs
pantoprazole
03
Conditions
cisplatin-induced nephrotoxicity (CIN)
Beyond the preview
Go deeper on NCT04217512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04217512.